m7-FLIPI identifies patients with early disease progression of FL after therapy
The importance of collaboration across fields and institutions
Graft-versus-host disease (GvHD): Advances at EBMT 2016
Prognostic markers for CLL - how do they help determine who gets which treatment?
Why aren’t cytogenetic analyses being implemented into clinical studies of CLL?